Overview
Stephen Jesmajian is a primary care provider, practicing in Internal Medicine in New Rochelle, New York. Dr. Jesmajian is rated as an Experienced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are COVID-19, Sepsis, Empyema, Pneumonia, and Gastrostomy.
His clinical research consists of co-authoring 30 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE SNP
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- MEDICARE SNP
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- PPO
- EPO
- HMO
- PPO
- MEDICARE-MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
29 Glover Johnson Place, New Rochelle, NY 10802
16 Guion Place, New Rochelle, NY 10550
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Northeast Medical Group Inc
Robert Henry is a primary care provider, practicing in Internal Medicine in New Haven, Connecticut. Dr. Henry is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Blood Clots, and Metabolic Syndrome.
Hudson MD Group
Chang Lee is a primary care provider, practicing in Internal Medicine in Fort Lee, New Jersey. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 2 Diabetes (T2D), High Cholesterol, Folate Deficiency, and Multiple Carboxylase Deficiency. Dr. Lee is currently accepting new patients.
Tapestry Telehealth PLLC
David Chess is a primary care provider, practicing in Geriatrics and Internal Medicine in Freehold, New Jersey. Dr. Chess is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Hypertension, and Heart Failure. Dr. Chess is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- COVID-19Dr. Jesmajian isAdvanced. Learn about COVID-19.
- SepsisDr. Jesmajian isAdvanced. Learn about Sepsis.
- Experienced
- Acute Coronary SyndromeDr. Jesmajian isExperienced. Learn about Acute Coronary Syndrome.
- Acute Respiratory Distress Syndrome (ARDS)Dr. Jesmajian isExperienced. Learn about Acute Respiratory Distress Syndrome (ARDS).
- Atypical PneumoniaDr. Jesmajian isExperienced. Learn about Atypical Pneumonia.
- CellulitisDr. Jesmajian isExperienced. Learn about Cellulitis.
- Chronic Kidney DiseaseDr. Jesmajian isExperienced. Learn about Chronic Kidney Disease.
- Chronic Obstructive Pulmonary Disease (COPD)Dr. Jesmajian isExperienced. Learn about Chronic Obstructive Pulmonary Disease (COPD).